Remove BioTech Remove Health Policy Remove Life Science
article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech 270
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Interestingly, these are two of the most prominent life science companies that have been part of Operation Warp Speed to accelerate the development of COVID-19 vaccines.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs. The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.

BioTech 199
article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

The Kaiser Family Foundation has been tracking this topic for a few years, and this month, their March 2019 Health Tracking Poll shows vast majorities of Democrats, Independents and Republicans all share these sentiments. There’s little Americans, by political party, agree upon in 2019.